ERBB2 and cancer: LDLR hyperexpression in HER2-positive tumour cells and triple-negative BC phenotypes were found associated with increased invasion [62,63], while the LDLR downregulation in BC cells was reported to enhance cancer cell death and reduce the tumour growth in the BC hyperlipidaemia model [64,65].